In 2022, the global Veterinary Regenerative Medicine Market is expected to be worth USD 284.5 million.
The Veterinary Regenerative Medicine Market is estimated to increase at a CAGR of 13.80% between 2023 and 2030, reaching USD 800.2 Million in 2030.
The stem cell category had the highest revenue share in 2022
The orthopedic diseases category generates the majority of the revenue in the veterinary regenerative medicine industry.
The research institutes segment is expected to grow at the quickest CAGR in the near future.